Christopher M. Blanchette, PhD
Articles
January 24th 2011
Relationship Between Short-Acting β-Adrenergic Agonist Use and Healthcare Costs
Harris S. Silver, MD Christopher M. Blanchette, PhD Shital Kamble, PhD Hans Petersen, MS Matthew A. Letter, BS David Meddis, PhD Benjamin Gutierrez, PhD
Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs.
July 15th 2008
Economic Assessment of Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
Manabu Akazawa, PhD D. Cortney Hayflinger, MS Richard H. Stanford, PharmD Christopher M. Blanchette, PhD
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma
